Effect of pre-gestational stress and prenatal venlafaxine administration on cardiovascular system of rat offspring

Open access

Abstract

A number of pregnant women all over the world suffer from depression and are treated during gestation with antidepressants, mostly with selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors. Exposure to prenatal stress is also a great risk factor for a developing fetus and could be responsible for altered fetal development or various neurobehavioral disturbances of a child. Administration of selective serotonin and norepinephrine reuptake inhibitor venlafaxine is associated with various cardiovascular adverse effects, such as tachycardia, increased blood pressure, arrhythmias and hypertensive crisis. The aim of this study was to focus on the effect of pre-gestational chronic mild unpredictable stress and/or administration of antidepressant venlafaxine (10 mg/kg/day, p. o.) on specific parameters, determining the function of the cardiovascular system of male and female rat offspring. Blood pressure and standard ECG were recorded in the offspring. Exposure to pre-gestational stress did not cause significant changes in the systolic, diastolic blood pressure and pulse frequency either in males or in females, compared to the unexposed control animals. Pre-gestational stress caused the shortening of QT interval and prolongation of QRS complex duration in males. On the other hand, in females, the effects of pre-gestational stress were potentiated by the administration of venlafaxine and resulted in elevated systolic and diastolic blood pressure, prolonged QT interval and shortened QRS complex duration, compared to the control. In conclusion, the female rat offspring are more sensitive to exposure to pre-gestational, to chronic mild unpredictable stress and venlafaxine.

[1] Bavle A. Venlafaxine induced QTc interval prolongation in a therapeutic dose. Asian J Psychiatr. 2015;16:63-64.

[2] Bourke CH, Stowe ZN, Neigh GN et al. Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats. Neurotoxicol Teratol. 2013;39:100-109.

[3] Bögi E, Belovičová K, Csatlósová K et al. Impact of pre-gestational stress on offspring neurobehavioral development and hippocampal functioning. Interdiscip Toxicol. 2018;11(1):75.

[4] Capello CF, Bourke CH, Ritchie JC et al. Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk. J Pharmacol Exp Ther. 2011;339(1):275-285.

[5] Ciuna A, Andretta M, Corbari L et al. Are we going to increase the use of antidepressants up to that of benzodiazepines? Eur J Clin Pharmacol. 2004;60:629-634.

[6] Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335(14):1010-1015.

[7] Chambers CD, Hernandez-Diaz S, Van Marter LJ et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354(6):579-587.

[8] Csatlósová K, Bögi E, Belovičová K, Dubovický M. Unpredictable chronic mild stress as an animal model of depression. Interdiscip Toxicol. 2018;11(1):87.

[9] Dubovický M, Császárová E, Brnoliaková Z, Ujházy E, Navarová J, Mach M. Effect of prenatal administration of venlafaxine on postnatal development of rat offspring. Interdiscip Toxicol. 2012;5(2):92-97.

[10] Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry. 1995;56(12):574-579.

[11] Furu K, Kieler H, Haglund B et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350:h1798.

[12] Gemmel M, Bögi E, Ragan C et al. Perinatal selective serotonin reuptake inhibitor medication (SSRI) effects on social behaviors, neurodevelopment and epigenome. Neurosci Biobehav Rev. 2018;85:102-116.

[13] Gergs U, Neumann J, Simm A, Silber R-E, Remmers FO, Läer S. Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium. Naunyn Schmiedebergs Arch Pharmacol. 2009;379(4):349-359.

[14] Hanley GE and Oberlander TF. The effect of perinatal exposures on the infant: antidepressants and depression. Best Pract Res Clin Obstet Gynaecol. 2014;28(1):37-48.

[15] Howell C, Wilson AD, Waring WS. Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol. 2007;64(2):192-197.

[16] Huang Y, Xu H, Li H, Yang H, Chen Y, Shi X. Pre-gestational stress reduces the ratio of 5-HIAA to 5-HT and the expression os 5-HT1A receptor and serotonin transporter in the brain of foetal rat. BMC Neurosci. 2012;13:22.

[17] Johnson EM, Whyte E, Mulsant BH et al. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry. 2006;14:796-802.

[18] Kallen B. Fluoxetine use in early pregnancy. Birth Defects Res B Dev Reprod Toxicol. 2004;71(6):395-396.

[19] Khurana RN and Baudendistel TE. Hypertensive crisis associated with venlafaxine administration. Am J Med. 2003;115(8):676-677.

[20] Kim J, Riggs KW, Misri S et al. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breastfeeding. Br J Clin Pharmacol. 2006;61(2):155-163.

[21] Kiryanova V, Meunier SJ, Dyck R H. Behavioural outcomes of adult female offspring following maternal stress and perinatal fluoxetine exposure. Behav Brain Res. 2017;331:84-91.

[22] Kivrak Y, Guvenc TS, Akbulut N et al. Accelerated hypertension after venlafaxine usage. Case report in Psychiatry. 2014;2014,Article ID 659715, 4 pages.

[23] Louik C, Lin AE, Werler MM, Hernandéz-Días S, Mitchell AA. Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356(26):2675-2683.

[24] Moses-Kolko EL, Bogen D, Perel J et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005;293(19):2372-2383.

[25] Mueller BR, Bale TL.Impact of prenatal stress on long term body weight in dependent on timing and maternal sensitivity. Psychol Behav. 2006;88:605-614.

[26] Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci. 2008;28(36):9055-9065.

[27] Nebigil CG, Choi D-S, Dierich A et al. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci U.S.A. 2000;97(17):9508-9513.

[28] Newport DJ, Stowe ZN, Nemeroff CB. Parental depression: animal models of an adverse life event. Am J Psychiatry. 2002;159:1265-83.

[29] Newport DJ, Hostetter AL, Juul SH, Porterfield SM, Knight BT, Stowe ZN. Prenatal psychostimulant and antidepressant exposure and the risk of hypertensive disorder of pregnancy. J Clin Psychiatry. 2016;77(11):1538-1545.

[30] Sari Y and Zhou FC. Serotonin and its transporter on proliferation of fetal heart cells. Int J Dev Neurosci. 2003;21(8):417-424.

[31] St-Pierre J, Laurent L, King S, Vaillancourt C. Effects of prenatal maternal stress on serotonin and fetal development. Placenta. 2016;48(30):S66-71.

[32] Szuran TF, Pliška V, Pokorny J, Welzl H. Prenatal stress in rats: effects on plasma corticosterone, hippocampal glucocorticoid receptors, and maze performance. Physiol Behav. 2000,71(3-4):353-362.

[33] Toh S, Mitchell AA, Louik C, Werler M, Chambers CD, Hernandéz-Díaz S. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry. 2009;166(3):320-328.

[34] Toscano AE, Amorim MA, deCarvalho Filho EV et al. Do malnutrition and fluoxetine neonatal treatment program alterations in heart morphology? Life Sci. 2008;82(21-22):1131-1136.

[35] Zeskind PS and Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113(2):368-375.

European Pharmaceutical Journal

Acta Facultatis Pharmaceuticae Universitatis Comenianae (formerly)

Journal Information


CiteScore 2017: 0.24

SCImago Journal Rank (SJR) 2017: 0.129
Source Normalized Impact per Paper (SNIP) 2017: 0.140

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 120 120 68
PDF Downloads 81 81 38